1,861 results on '"Tada, Hiroshi"'
Search Results
52. L-type amino acid transporter 1 is associated with chemoresistance in breast cancer via the promotion of amino acid metabolism
53. Significance of day-to-day glucose variability in patients after acute coronary syndrome
54. Serum tenascin-C levels in atrium predict atrial structural remodeling processes in patients with atrial fibrillation
55. The P wave morphology in lead V7 on the synthesized 18-lead ECG is a useful parameter for identifying arrhythmias originating from the right inferior pulmonary vein
56. Papillary Muscle Ventricular Tachycardia
57. SVC Mapping Using an Ultra-High Resolution 3-Dimensional Mapping System in Patients With and Without AF
58. The anti-angiogenic agent lenvatinib induces tumor vessel normalization and enhances radiosensitivity in hepatocellular tumors
59. Does second-generation cryoballoon ablation using the current single short freeze strategy produce pulmonary vein stenosis?
60. MO10-2 Clinical decisions by the Molecular Tumor Board on comprehensive genomic profiling tests in Japan: A retrospective observational study
61. Symptomatic periesophageal vagal nerve injury by different energy sources during atrial fibrillation ablation
62. Contrast‐enhanced computed tomography in the venous rather than the arterial phase is essential for the evaluation of the right phrenic nerve
63. Comprehensive validation of early diagnostic algorithms for myocardial infarction in the emergency department
64. Changes in cell-free DNA after short-term palbociclib and fulvestrant treatment for advanced or metastatic hormone receptor-positive and human epidermal growth factor 2-negative breast cancer
65. Treatment with catheter ablation for patients with arrhythmia-induced cardiomyopathy caused by atrial fibrillation promises a good prognosis
66. Effects of door‐to‐tolvaptan time on short‐term clinical outcome in patients with acute heart failure
67. Sex differences in idiopathic ventricular arrhythmias
68. Contributors
69. Mitochondrial Cardiomyopathy and Usage of l-Arginine
70. Atrioventricular conduction disturbance during pulmonary vein isolation using the second-generation cryoballoon — Vagal impact of cryoballoon ablation
71. Importance of latissimus dorsi muscle preservation for shoulder function after scapulectomy
72. Early repolarization in the inferolateral leads predicts the presence of vasospastic angina: a novel predictor in patients with resting angina
73. Reproductive history and breast cancer survival: a prospective patient cohort study in Japan
74. Intra-procedural evaluation of the cavo-tricuspid isthmus anatomy with different techniques: comparison of angiography and intracardiac echocardiography
75. Catheter ablation of paroxysmal atrial fibrillation in patients with sick sinus syndrome
76. Endothelial damage and thromboembolic risk after pulmonary vein isolation using the latest ablation technologies: a comparison of the second-generation cryoballoon vs. contact force-sensing radiofrequency ablation
77. The impact of the CartoSound® image directly acquired from the left atrium for integration in atrial fibrillation ablation
78. Atrial fibrillation activation patterns predict freedom from arrhythmias after catheter ablation: utility of ExTRa mapping™
79. Impaired myocardial microcirculation in the flow-glucose metabolism mismatch regions in revascularized acute myocardial infarction
80. Minimal impact of postmastectomy radiation therapy on locoregional recurrence for breast cancer patients with 1 to 3 positive lymph nodes in the modern treatment era
81. Correction to: Trastuzumab, pertuzumab, and eribulin mesylate versus trastuzumab, pertuzumab, and a taxane as a first-line or second-line treatment for HER2-positive, locally advanced or metastatic breast cancer: study protocol for a randomized controlled, non-inferiority, phase III trial in Japan (JBCRG-M06/EMERALD)
82. Trastuzumab, pertuzumab, and eribulin mesylate versus trastuzumab, pertuzumab, and a taxane as a first-line or second-line treatment for HER2-positive, locally advanced or metastatic breast cancer: study protocol for a randomized controlled, non-inferiority, phase III trial in Japan (JBCRG-M06/EMERALD)
83. Mitochondrial dynamics as a novel treatment strategy for triple‐negative breast cancer.
84. List of Contributors
85. Ablation of Idiopathic Left and Right Ventricular and Fascicular Tachycardias
86. Can the Durability of Pulmonary Vein Isolation Be Predicted by the Time-to-Isolation in Second-Generation Cryoballoon Ablation?: Insight From the Results of Repeat Procedures
87. Association of plasma pentraxin-3 levels with coronary risk factors and the lipid profile: a cross-sectional study in Japanese patients with stable angina pectoris
88. Angioscopy Using CO2 for Femoropopliteal Occlusive Disease
89. Influence of Monitoring and Atrial Arrhythmia Burden on Quality of Life and Healthcare Utilization in Patients Undergoing Pulsed Field Ablation: A Secondary Analysis of the PULSED AF Trial
90. LB-456089-4 INFLUENCE OF ATRIAL ARRHYTHMIA BURDEN ON QUALITY OF LIFE IN PATIENTS UNDERGOING PULSED FIELD ABLATION: A SUB-STUDY OF THE PULSED AF TRIAL
91. Targeting DRP1 mediated mitochondrial metabolism as a novel treatment strategy for triple negative breast cancer (TNBC)
92. Clinical Significance of ABCG2/BCRP Quantified by Fluorescent Nanoparticles in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy
93. Supplementary Figure 3 from In vivo Real-time Tracking of Single Quantum Dots Conjugated with Monoclonal Anti-HER2 Antibody in Tumors of Mice
94. Supplementary Figure 2 from In vivo Real-time Tracking of Single Quantum Dots Conjugated with Monoclonal Anti-HER2 Antibody in Tumors of Mice
95. Supplementary Figure 1 from In vivo Real-time Tracking of Single Quantum Dots Conjugated with Monoclonal Anti-HER2 Antibody in Tumors of Mice
96. Supplementary Figure Legends 1-3 from In vivo Real-time Tracking of Single Quantum Dots Conjugated with Monoclonal Anti-HER2 Antibody in Tumors of Mice
97. Peri-procedural anticoagulation in patients with end-stage kidney disease undergoing atrial fibrillation ablation: results from the multicentre end-stage kidney disease–atrial fibrillation ablation registry
98. Abstract P3-05-15: Clinical significance of breast cancer resistance protein (BCRP) quantified by fluorescence nanoparticle in breast cancer patients undergoing neoadjuvant chemotherapy
99. Symptomatic Gastroparesis After Cryoballoon-Based Atrial Fibrillation Ablation: Results From a Large Multicenter Registry
100. Association of CD34/CD133/VEGFR2-Positive Cell Numbers with Eicosapentaenoic Acid and Postprandial Hyperglycemia in Patients with Coronary Artery Disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.